Advertisement
Myocardial infarction

Employment, Earning Losses Noted After Cardiovascular Events

0
Fewer patients admitted to hospital for MI, cardiac arrest, stroke working at three years postevent
Income volatility and drops in income during formative earning years are associated with an increased risk for cardiovascular disease and all-cause mortality

Income Volatility Linked to CVD, All-Cause Mortality

0
Increased risk seen with income volatility, more income drops during formative earning years
Population-level data can help medical practitioners use electronic health records to identify patients at risk for cardiovascular disease

Applying Population Health Data IDs Patients at Risk for CVD

0
Patients at risk for cardiovascular disease identified even with missing electronic health record data
Psoriasis is associated with an increased risk for cardiovascular interventions in patients with hypertension

Hypertension With Psoriasis Tied to More Cardiac Interventions

0
In patients with hypertension, psoriasis linked to increased risk for cardiovascular procedures, surgeries
For patients with heart failure

In-Hospital Morbidity, Mortality Up With Flu in Heart Failure

0
Higher incidence seen for in-hospital mortality, acute respiratory failure, acute kidney injury
Patients with hypertension with progression of periventricular white matter hyperintensities have an increased risk for incident mild cognitive impairment

Risk for MCI Up With Progressive Cerebral Small Vessel Disease

0
Patients with hypertension with progressive cSVD have increased risk for mild cognitive impairment
There is no compelling evidence to indicate health benefits of nonsugar sweetener use on a range of health outcomes

Health Benefits of Nonsugar Sweeteners Uncertain

0
However, large systematic review could not rule out harms from nonsugar sweeteners
For older adults with heart failure

Moderate Drinking Not Harmful for Seniors With Heart Failure

0
Compared with abstinence from alcohol, increased survival seen with moderate drinking

December 2018 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for December 2018. This roundup includes the latest...
For patients with a recent acute coronary syndrome receiving a statin

Price of Alirocumab Would Have to Be Cut to Be Cost-Effective

0
Price of alirocumab would have to decrease from original cost of $14,560 to $1,974 to be cost-effective